The results are worth the wait, however. Even though the nature of the process means that sales cycles can take many years and expansion through new projects can be slow, once established, there is a steady, predictable and defensive revenue stream.
Consort Medical PLC CEO Jonathan Glenn stresses that the drug delivery industry's share of the pharma pie is small,...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?